Oct 7 (Reuters) – AstraZeneca said on Tuesday its drug Baxdrostat met the main goal in a late-stage study in patients with treatment-resistant high blood pressure, or hypertension. (Reporting by Raechel Thankam Job in Bengaluru; Editing by Mrigank Dhaniwala)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Corrects dateline to Oct 7, not Oct 6. No change to text) By America Hernandez…
(Reuters) -Comedians in Congo are mining their country's chronic instability for laughs, entertaining people displaced…
SPOT SILVER FALLS OVER 1% TO $47.71/OZ (The article has been published through a syndicated…
(Reuters) -Toyota Motor is recalling 393,838 vehicles in the U.S. due to a rearview camera…
(Reuters) -Comedians in Congo are mining their country's chronic instability for laughs, entertaining people displaced…
Oct 7 (Reuters) - Saudi Arabia's Public Investment Fund has set initial price guidance for…